Phase II California Cancer consortium trial of gemcitabine-eribulin combination in cisplatin-ineligible patients with metastatic urothelial carcinoma: Final Report (NCI-9653)

Sarmad Sadeghi, Susan G. Groshen, Denice D. Tsao-Wei, Rahul Parikh, Amir Mortazavi, Tanya B. Dorff, Cheryl Kefauver, Christopher Hoimes, Laurence Doyle, David I. Quinn, Edward Newman, Primo N. Lara

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II California Cancer consortium trial of gemcitabine-eribulin combination in cisplatin-ineligible patients with metastatic urothelial carcinoma: Final Report (NCI-9653)'. Together they form a unique fingerprint.

Medicine & Life Sciences